Search research articles
Contact Us
Filters
Showing results (431-440 of 484) with videos related to
Page
of 49
Sort By:
Diabetes, Obesity & Metabolism
|
March 26, 2021
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial
Clare Arnott, Jing-Wei Li, Christopher P Cannon, et al.
BMJ Open Diabetes Research & Care
|
June 13, 2023
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
David M Charytan, Kenneth W Mahaffey, Meg J Jardine, et al.
Circulation
|
April 8, 2022
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials
Brendon L Neuen, Megumi Oshima, Rajiv Agarwal, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
November 20, 2020
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m<sup>2</sup>: Subgroup Analysis of the Randomized CREDENCE Trial
George Bakris, Megumi Oshima, Kenneth W Mahaffey, et al.
The Lancet. Neurology
|
April 9, 2008
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial
Craig S Anderson, Yining Huang, Ji Guang Wang, et al.
The New England Journal of Medicine
|
June 10, 2008
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
, Anushka Patel, Stephen MacMahon, et al.
Lancet (London, England)
|
February 14, 2017
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
Clara K Chow, Jay Thakkar, Alex Bennett, et al.
JAMA Network Open
|
December 8, 2021
Factors Associated With the Use of a Salt Substitute in Rural China
Yishu Liu, Hongling Chu, Ke Peng, et al.
Journal of the American Heart Association
|
August 5, 2022
Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial
Jing-Wei Li, Clare Arnott, Hiddo J L Heerspink, et al.
BMJ Open
|
July 21, 2021
Protocol for the economic evaluation of the China Salt Substitute and Stroke Study (SSaSS)
Ka-Chun Li, Maoyi Tian, Bruce Neal, et al.
Page
of 49
Search research articles
Search
Showing results (431-440 of 484) with videos related to
Sort By:
Page
of 49
Diabetes, Obesity & Metabolism
|
March 26, 2021
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial
Clare Arnott, Jing-Wei Li, Christopher P Cannon, et al.
BMJ Open Diabetes Research & Care
|
June 13, 2023
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
David M Charytan, Kenneth W Mahaffey, Meg J Jardine, et al.
Circulation
|
April 8, 2022
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials
Brendon L Neuen, Megumi Oshima, Rajiv Agarwal, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
November 20, 2020
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m<sup>2</sup>: Subgroup Analysis of the Randomized CREDENCE Trial
George Bakris, Megumi Oshima, Kenneth W Mahaffey, et al.
The Lancet. Neurology
|
April 9, 2008
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial
Craig S Anderson, Yining Huang, Ji Guang Wang, et al.
The New England Journal of Medicine
|
June 10, 2008
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
, Anushka Patel, Stephen MacMahon, et al.
Lancet (London, England)
|
February 14, 2017
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
Clara K Chow, Jay Thakkar, Alex Bennett, et al.
JAMA Network Open
|
December 8, 2021
Factors Associated With the Use of a Salt Substitute in Rural China
Yishu Liu, Hongling Chu, Ke Peng, et al.
Journal of the American Heart Association
|
August 5, 2022
Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial
Jing-Wei Li, Clare Arnott, Hiddo J L Heerspink, et al.
BMJ Open
|
July 21, 2021
Protocol for the economic evaluation of the China Salt Substitute and Stroke Study (SSaSS)
Ka-Chun Li, Maoyi Tian, Bruce Neal, et al.
Page
of 49